Momentum Therapeutics (Biotechnology) Overview
- Year Founded
-
2024
- Status
-
Private
- Employees
-
5
- Latest Deal Type
-
Early Stage VC
- Latest Deal Amount
-
$2M
- Investors
-
3
Momentum Therapeutics (Biotechnology) General Information
Description
Developer of biotechnology therapeutics intended to address age-related neurodegenerative conditions by targeting aging-associated biological pathways. The company's platform integrates large-scale proteomics data, computational modelling, mapping of protein changes in brain tissue, and experimental validation in laboratory models to identify drug targets and therapeutic candidates, enabling biotechnology and pharmaceutical researchers to study protein dysfunction and develop treatments for neurodegenerative diseases.
Contact Information
Website
www.momentumtx.bioCorporate Office
- 477 Madison Avenue
- 6th Floor
- New York, NY 10022
- United States
Corporate Office
- 477 Madison Avenue
- 6th Floor
- New York, NY 10022
- United States
Momentum Therapeutics (Biotechnology) Timeline
Momentum Therapeutics (Biotechnology) Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Early Stage VC | 01-Mar-2026 | $2M | Completed | Startup | ||
| 2. Accelerator/Incubator | 26-Mar-2025 | Completed | Startup | |||
| 1. Accelerator/Incubator | 01-Jan-2025 | Completed | Startup |
Momentum Therapeutics (Biotechnology) Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Momentum Therapeutics (Biotechnology) Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Momentum Therapeutics (Biotechnology) Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Humboldt Fund | Venture Capital | Minority | ||
| Zentynel Frontier Investments | Venture Capital | Minority | ||
| Harvard Innovation Launch Lab | Accelerator/Incubator |
Momentum Therapeutics (Biotechnology) FAQs
-
When was Momentum Therapeutics (Biotechnology) founded?
Momentum Therapeutics (Biotechnology) was founded in 2024.
-
Where is Momentum Therapeutics (Biotechnology) headquartered?
Momentum Therapeutics (Biotechnology) is headquartered in New York, NY.
-
What is the size of Momentum Therapeutics (Biotechnology)?
Momentum Therapeutics (Biotechnology) has 5 total employees.
-
What industry is Momentum Therapeutics (Biotechnology) in?
Momentum Therapeutics (Biotechnology)’s primary industry is Biotechnology.
-
Is Momentum Therapeutics (Biotechnology) a private or public company?
Momentum Therapeutics (Biotechnology) is a Private company.
-
What is Momentum Therapeutics (Biotechnology)’s current revenue?
The current revenue for Momentum Therapeutics (Biotechnology) is .
-
How much funding has Momentum Therapeutics (Biotechnology) raised over time?
Momentum Therapeutics (Biotechnology) has raised $2M.
-
Who are Momentum Therapeutics (Biotechnology)’s investors?
Humboldt Fund, Zentynel Frontier Investments, and Harvard Innovation Launch Lab have invested in Momentum Therapeutics (Biotechnology).
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
